We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
LATNOP, LATNOPROS, LATNOPROST, LATNOT (Neo Health (Australia) Pty Ltd)
Product name
LATNOP, LATNOPROS, LATNOPROST, LATNOT
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
169 working days (255)
Active ingredients
Latanoprost
Registration type
New generic medicine
Indication
LATNOP, LATNOPROS, LATNOPROST, LATNOT (eye drops) is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.